This page lists all pharmaceutical reports related to the field of Infectious Diseases. The reports include market research reports and pipeline analyses.
Displaying 151 - 170 of 170 results
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Septic Shock - Pipeline Review, H2 2011
- AIDS - Related Cancers - Pipeline Review, H2 2011
- Seasonal Influenza Vaccine Market in Asia - Pacific Region - Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth
- Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets
- Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment
- Anti-Bacterials Market to 2016 - Cephalosporins, Penicillins, Macrolides and Fluoroquinolones to Drive the Anti-Bacterials Market
- Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- HIV/AIDS Therapeutics Market to 2017 - Superior Combination Therapies and Decreasing Mortality to Sustain Market Growth Despite Major Patent Expiries
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- HIV-Associated Lipodystrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2018
- Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Meningitis - Pipeline Assessment and Market Forecasts to 2018
- Pneumococcal Infections - Pipeline Assessment and Market Forecasts to 2017
- Staphylococcal Infections Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Leprosy Global Clinical Trials Review, H2, 2011